Combigene AB - ESG Rating & Company Profile powered by AI
The webpage is a zero-cost ESG analysis for Combigene AB. Other companies in the rating industry group for Combigene AB are shownin the table. The assessment of Combigene AB employs data points from across the internet as well as from public disclosures by Combigene AB.
Combigene AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.8; made up of an environmental score of 5.3, social score of 6.4 and governance score of 2.7.
4.8
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1082 | Respiratorius AB (publ) | 4.9 | High |
| 1082 | Shenzhen Chipscreen Biosciences Co Ltd | 4.9 | High |
| 1121 | Combigene AB | 4.8 | High |
| 1121 | Heat Biologics Inc | 4.8 | High |
| 1121 | Curis Inc | 4.8 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Combigene AB have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Combigene AB disclose current and historical energy intensity?
Sign up for free to unlockDoes Combigene AB report the average age of the workforce?
Sign up for free to unlockDoes Combigene AB reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Combigene AB disclose its ethnicity pay gap?
Sign up for free to unlockDoes Combigene AB disclose cybersecurity risks?
Sign up for free to unlockDoes Combigene AB offer flexible work?
Sign up for free to unlockDoes Combigene AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Combigene AB disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Combigene AB conduct supply chain audits?
Sign up for free to unlockDoes Combigene AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Combigene AB conduct 360 degree staff reviews?
Sign up for free to unlockDoes Combigene AB disclose the individual responsible for D&I?
Sign up for free to unlockDoes Combigene AB disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Combigene AB disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Combigene AB disclose water use targets?
Sign up for free to unlockDoes Combigene AB have careers partnerships with academic institutions?
Sign up for free to unlockDid Combigene AB have a product recall in the last two years?
Sign up for free to unlockDoes Combigene AB disclose incidents of discrimination?
Sign up for free to unlockDoes Combigene AB allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Combigene AB issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Combigene AB disclose parental leave metrics?
Sign up for free to unlockDoes Combigene AB disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Combigene AB disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Combigene AB disclose the pay ratio of women to men?
Sign up for free to unlockDoes Combigene AB support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Combigene AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Combigene AB reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Combigene AB involved in embryonic stem cell research?
Sign up for free to unlockDoes Combigene AB disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Combigene AB disclose its waste policy?
Sign up for free to unlockDoes Combigene AB report according to TCFD requirements?
Sign up for free to unlockDoes Combigene AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Combigene AB disclose energy use targets?
Sign up for free to unlockDoes Combigene AB disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Combigene AB have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Combigene AB
These potential risks are based on the size, segment and geographies of the company.
CombiGene AB (publ) engages in the development of gene therapy for severe life-altering diseases in Sweden. The company is developing two gene therapy candidates, including CG01, which is in preclinical studies for the treatment of epilepsy and biodistribution and toxicology studies; and CGT2 for the treatment of lipodystrophy. The company has a licensing and collaboration agreement with Lipigon Pharmaceuticals AB to develop a gene therapy treatment for partial lipodystrophy; and with Spark Therapeutics to develop adeno-associated virus (AAV) based gene therapies. CombiGene AB (publ) was founded in 1999 and is headquartered in Lidingö, Sweden.